Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a note that publications are auto-filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed-origin publications description that referenced revision v3.2.0.SummaryDifference0.0%

- Check31 days agoChange DetectedStudy Locations updated: added 'Tainan, Taiwan, 71004' and removed 'Tainan City, Taiwan, 71004' from the locations list.SummaryDifference0.1%

- Check45 days agoChange DetectedNo additions or deletions detected; the Study Details page content remains unchanged.SummaryDifference0.1%

- Check52 days agoChange DetectedPublications section updated: added Secord et al., Molecular Characterization and Clinical Implications of Endometrial Cancer (Obstet Gynecol, 2025; 146(5):660-671; Epub 2025 Sep 18), and removed the previous 'Online ahead of print' listing for the same article. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedExpanded and detailed trial protocol and site information for selinexor maintenance in endometrial cancer, with updated eligibility, endpoints, and locations; replaces a shorter prior description.SummaryDifference31%

- Check76 days agoChange DetectedPage updated to version v3.2.0 with extensive new contact details added; older v3.0.2 deletion indicates a release upgrade. The main change is a content and contact-data refresh.SummaryDifference0.0%

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.